**Work Group Co-Chairs**

Gavin J Becker, MD, FRACP Royal Melbourne Hospital Melbourne, Australia

David C Wheeler, MD, FRCP University College London London, United Kingdom

**Work Group**

Dick de Zeeuw, MD, PhD University Medical Center Groningen Groningen, Netherlands

Toshiro Fujita, MD University of Tokyo School of Medicine Tokyo, Japan

Susan L Furth, MD, PhD The Children\'s Hospital of Philadelphia Philadelphia, PA, USA

Hallvard Holdaas, MD, PhD Hospital Rikshospitalet Oslo, Norway

Shanthi Mendis, MBBS, MD, FRCP, FACC World Health Organization Geneva, Switzerland

Suzanne Oparil, MD University of Alabama Birmingham, AL, USA

Vlado Perkovic, MBBS, FRACP, FASN, PhD George Institute for International Health Sydney, Australia

Cibele Isaac Saad Rodrigues, MD, PhD Catholic University of São Paulo São Paulo, Brazil

Mark J Sarnak, MD, MS Tufts Medical Center Boston, MA, USA

Guntram Schernthaner, MD Rudolfstiftung Hospital Vienna, Austria

Charles R V Tomson, DM, FRCP Southmead Hospital Bristol, United Kingdom

Carmine Zoccali, MD CNR-IBIM Clinical Research Unit, Ospedali Riuniti Reggio Calabria, Italy

**Evidence Review Team**

**Tufts Center for Kidney Disease Guideline Development and Implementation, Tufts Medical Center, Boston, MA, USA:**

Katrin Uhlig, MD, MS, Project Director; Director, Guideline Development

Ashish Upadhyay, MD, Assistant Project Director

Amy Earley, BS, Project Coordinator

Shana Haynes, MS, DHSc, Research Assistant

Jenny Lamont, MS, Project Manager

**In addition, support and supervision were provided by:**

Ethan M Balk, MD, MPH; Program Director, Evidence Based Medicine
